Patricia Huelin

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Real-World Outcomes of Opti-Hep-D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care.

Real-World Outcomes of Opti-Hep-D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 30, 2026

Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study.

Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study.

Journal: Journal of hepatology

Published: November 14, 2024

Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure.

Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure.

Journal: JHEP reports : innovation in hepatology

Published: October 01, 2021

Congestive Hepatopathy.

Congestive Hepatopathy.

Journal: International journal of molecular sciences

Published: October 30, 2020

Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain.

Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain.

Journal: Journal of clinical medicine

Published: October 06, 2020

Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders.

Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders.

Journal: Journal of clinical medicine

Published: July 26, 2020

Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.

Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.

Journal: Gastroenterology

Published: March 16, 2020

Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.

Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.

Journal: Cells

Published: October 27, 2019

Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes.

Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes.

Journal: Journal of hepatology

Published: February 19, 2019

LOXL2-A New Target in Antifibrogenic Therapy?

LOXL2-A New Target in Antifibrogenic Therapy?

Journal: International journal of molecular sciences

Published: January 21, 2019

Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study.

Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study.

Journal: Hepatology (Baltimore, Md.)

Published: October 25, 2018

Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.

Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 16, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026